These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 8796135

  • 1. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G, Izzo G, La Montagna G, Bellastella A.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
    Hitz MF, Jensen JE, Eskildsen PC.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
    [Abstract] [Full Text] [Related]

  • 3. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 4. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial.
    Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R.
    J Bone Miner Res; 2002 Jun; 17(6):1081-94. PubMed ID: 12054164
    [Abstract] [Full Text] [Related]

  • 5. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
    Brixen K, Kassem M, Nielsen HK, Loft AG, Flyvbjerg A, Mosekilde L.
    J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 7. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
    Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M.
    J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
    [Abstract] [Full Text] [Related]

  • 8. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 9. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug 15; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

  • 10. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
    Kotzmann H, Riedl M, Bernecker P, Clodi M, Kainberger F, Kaider A, Woloszczuk W, Luger A.
    Calcif Tissue Int; 1998 Jan 15; 62(1):40-6. PubMed ID: 9405732
    [Abstract] [Full Text] [Related]

  • 11. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G.
    J Pediatr; 1993 Jan 15; 122(1):37-45. PubMed ID: 8419613
    [Abstract] [Full Text] [Related]

  • 12. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A.
    J Nephrol; 2004 Jan 15; 17(1):87-94. PubMed ID: 15151263
    [Abstract] [Full Text] [Related]

  • 13. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R, Jakubowicz S.
    J Pediatr; 2002 Nov 15; 141(5):606-10. PubMed ID: 12410186
    [Abstract] [Full Text] [Related]

  • 14. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May 15; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 15. Effects of 24 months of growth hormone (GH) treatment on serum carboxylated and undercarboxylated osteocalcin levels in GH-deficient adults.
    Hubina E, Lakatos P, Kovács L, Szabolcs I, Rácz K, Tóth M, Szucs N, Góth MI.
    Calcif Tissue Int; 2004 Jan 15; 74(1):55-9. PubMed ID: 14508626
    [Abstract] [Full Text] [Related]

  • 16. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses.
    Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Saccá L, Bellastella A.
    J Clin Endocrinol Metab; 1993 Dec 15; 77(6):1671-6. PubMed ID: 8263158
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug 15; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 18. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC, Hopkins E, Glorieux FH, Chrousos GP, Reynolds JC, Gundberg CM, Reing CM.
    J Bone Miner Res; 2003 Feb 15; 18(2):237-43. PubMed ID: 12568401
    [Abstract] [Full Text] [Related]

  • 19. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A, Conte G, Conti A, Masala A, Alagna S, Rovasio P, Faglia G.
    J Endocrinol Invest; 2000 Jun 15; 23(6):356-61. PubMed ID: 10908162
    [Abstract] [Full Text] [Related]

  • 20. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency.
    Thorén M, Soop M, Degerblad M, Sääf M.
    Acta Endocrinol (Copenh); 1993 Jun 15; 128 Suppl 2():41-3. PubMed ID: 8342392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.